Impact of serum levels of AFP onresponse to treatment ingenotype 4 chronic HCV patients

Serum levels of neopterinin patients with hepatitis C virus relatedchronic liver disease

Evaluation of post interferon therapy changes in chronic HCV patients : Clinical, Doppler ultrasonography and histopathological study

Serum hepcidin levels in patients with chronic hepatitis C

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Aetiology of anemia in chronic HCV patients receiving pegylated interferon plus ribavirin

Diabetic chronic HCV patients and their response to interferon therapy

Impact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy

Serum ferritin and reduced glutathione concentrations in chronic hepatitis C patients treated with interferon-alpha